AMNEAL PHARMACEUTICALS, INC. Limited Liability Company (LLC) Members' Equity, Including Portion Attributable to Noncontrolling Interest
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Limited Liability Company (LLC) Members' Equity, Including Portion Attributable to Noncontrolling Interest of -$368.82 million as of 2018-03-31, per its 10-Q filed 2019-08-05.
Discontinued › Balance Sheet › Equity › Limited Liability Company (LLC) Members' Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2021-03-01
- 2018-03-31: Limited Liability Company (LLC) Members' Equity, Including Portion Attributable to Noncontrolling Interest -$368.82M.
- 2017-12-31: Limited Liability Company (LLC) Members' Equity, Including Portion Attributable to Noncontrolling Interest -$375.58M.
- 2016-12-31: Limited Liability Company (LLC) Members' Equity, Including Portion Attributable to Noncontrolling Interest -$175.94M.
- 2015-12-31: Limited Liability Company (LLC) Members' Equity, Including Portion Attributable to Noncontrolling Interest -$186.87M.
| Period end | Limited Liability Company (LLC) Members' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2018-03-31 | -$368.82M 10-Q · filed 2019-08-05 |
| 2017-12-31 | -$375.58M 10-K · filed 2021-03-01 |
| 2016-12-31 | -$175.94M 10-K · filed 2020-03-02 |
| 2015-12-31 | -$186.87M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |